ChemicalBook > Product Catalog > Pharmaceutical intermediates > Bulk Drug Intermediates > 9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID
9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID
9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID Basic information
- Product Name:
- 9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID
- Synonyms:
-
- 9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID
- PROSTAGLANDIN E3
- (5Z,11a,13E,15S,17Z) 11,15-dihydroxy-9-oxo-prosta-5,13,17-trien-1-oic acid
- (5Z,13E,15S,17Z)-11α,15-Dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid
- PGE3
- Prostaglandin E3 Exclusive
- Prosta-5,13,17-trien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11α,13E,15S,17Z)-
- Prosta-5,13,17-trien-1-oicacid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E,15S,17Z)-
- CAS:
- 802-31-3
- MF:
- C20H30O5
- MW:
- 350.45
- Mol File:
- 802-31-3.mol
More
Less
9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID Chemical Properties
- Melting point:
- 84.5-85.5 °C
- Boiling point:
- 541.0±50.0 °C(Predicted)
- Density
- 1.166±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMF: >100 mg/ml (from PGE2); DMSO: >100 mg/ml (from PGE2); Ethanol: >100 mg/ml (from PGE2); PBS pH 7.2: >5 mg/ml (from PGE2)
- form
- Liquid
- pka
- 4.75±0.10(Predicted)
- color
- Colorless to light yellow
More
Less
9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID Usage And Synthesis
Uses
Prostaglandin E3 (PGE3) is formed via the cyclooxygenase (COX) metabolism of eicosapentaenoic acid. In human ocular tissue, it comprises 2.4% of the COX products formed. When applied to the eyes of a rabbit, a 1 μg dose of PGE3 decreases intraocular pressure from 21 mmHg to about 17 mmHg.
Definition
ChEBI: Prostaglandin E3 is a prostaglandins E. It has a role as a human metabolite. It is a conjugate acid of a prostaglandin E3(1-).
in vivo
Prostaglandin E3 (1 μmol/L; i.p.) modulates macrophage polarization towards an anti-inflammatory function in LPS (HY-D1056) (5 mg/kg)-induces acute inflammation model[1].
Prostaglandin E3 (1 μmol/L; every 3 days for 4 weeks) shows anti-tumor activity by regulates macrophage polarization[1].
| Animal Model: | 5 weeks, Nude mice (BABL/c) (PC3 xenograft model)[1] |
| Dosage: | 1 μmol/L for 50 μL |
| Administration: | Injected next to the tumour, every 3 days for 4 weeks |
| Result: | Decreased the weights of transplanted tumours, inhibits the expression of CD68 and CD206. |
| Animal Model: | 6-8-week-old C57BL6/J mice[1] |
| Dosage: | LPS+ PGE3 (5 mg/kg + 1 μmol/L) |
| Administration: | I.p.; once |
| Result: | Significantly reduced MPMs with an M1-like phenotype and increased M2-like MPMs, inhibited inflammatory cytokine secretion in both the serum and MPM cell lysates. |
9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACIDSupplier
Shanghai Hongye Biotechnology Co. Ltd
- Tel
- 400-9205774
- sales@glpbio.cn
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
- Tel
- 18818260767
- sales@chemegen.com
Guangzhou Younan Technology Co., Ltd
- Tel
- 020-82000279 18988941452
- YN_research@163.com
Shanghai Universal Biotech Co.,Ltd
- Tel
- 15921930842 15921930842
- yh-wang@univ-bio.com